Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile - PubMed
- ️Sat Jan 01 2022
. 2022 Apr 27;10(2):e0273221.
doi: 10.1128/spectrum.02732-21. Epub 2022 Mar 30.
Romina Salpini 1 , Luca Carioti 1 , Francesca Alessandra Ambrosio 2 , Stefano D'Anna 1 , Leonardo Duca 1 , Giosuè Costa 2 3 , Maria Concetta Bellocchi 1 , Lorenzo Piermatteo 1 , Anna Artese 2 3 , Maria Mercedes Santoro 1 , Stefano Alcaro 2 3 , Valentina Svicher # 4 , Francesca Ceccherini-Silberstein # 1
Affiliations
- PMID: 35352942
- PMCID: PMC9045195
- DOI: 10.1128/spectrum.02732-21
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile
Mohammad Alkhatib et al. Microbiol Spectr. 2022.
Abstract
The process of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genetic diversification is still ongoing and has very recently led to the emergence of a new variant of concern (VOC), defined as Omicron or B.1.1.529. Omicron VOC is the most divergent variant identified so far and has generated immediate concern for its potential capability to increase SARS-CoV-2 transmissibility and, more worryingly, to escape therapeutic and vaccine-induced antibodies. Nevertheless, a clear definition of the Omicron VOC mutational spectrum is still missing. Herein, we provide a comprehensive definition and functional characterization (in terms of infectivity and/or antigenicity) of mutations characterizing the Omicron VOC. In particular, 887,475 SARS-CoV-2 Omicron VOC whole-genome sequences were retrieved from the GISAID database and used to precisely define its specific patterns of mutations across the different viral proteins. In addition, the functional characterization of Omicron VOC spike mutations was finely discussed according to published manuscripts. Lastly, residues characterizing the Omicron VOC and the previous four VOCs (Alpha, Beta, Gamma, and Delta) were mapped on the three-dimensional structure of the SARS-CoV-2 spike protein to assess their localization in the different spike domains. Overall, our study will assist with deciphering the Omicron VOC mutational profile and will shed more light on its clinical implications. This is critical considering that Omicron VOC is currently the predominant variant worldwide. IMPORTANCE The Omicron variant of concern (VOC) has a peculiar spectrum of mutations characterized by the acquisition of mutations or deletions rarely detected in previously identified variants, particularly in the spike glycoprotein. Such mutations, mostly residing in the receptor-binding domain, could play a pivotal role in enhancing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity (by increasing binding affinity for ACE2), jeopardizing spike recognition by therapeutic and vaccine-induced antibodies and causing diagnostic assay failure. To our knowledge, this is one of the first exhaustive descriptions of newly emerged mutations underlying the Omicron VOC and its biological and clinical implications.
Keywords: B.1.1.519; COVID-19; SARS-CoV-2; emerging variants; mutations; omicron; pandemic; variant of concern.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

(a) Schematic illustration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome and its variants of concern along with their relevant mutations that characterize each protein of interest. Mutations were defined as amino acid substitutions/deletions/insertions that occurred in 75% of sequences using the NC_045512.2 as the reference sequence. Residues in red are those that directly interact with ACE2. Mutations in bold black refer to the shared mutations by at least two variants of concern, while those in bold blue refer to the unique Omicron mutations. *Mutations at residues 417, 440, and 446 in the receptor-binding domain (RBD) spike represent original Omicron consensus according to earlier prevalence of greater than 75%, while currently, the new prevalence values are 51.3, 53.9, and 54,9%, respectively. (b) Spike mutations underlying the currently circulating Omicron sublineages BA.1, BA.1.1, BA.2, and BA.3. Blue color refers to those mutations shared by the four sublineages.

Three-dimensional representation of SARS-CoV-2 spike protein reporting residues characterizing the five variants of concern (VOCs). The protein is shown as a gray cartoon. The Alpha B.1.1.7, Beta B.1.351, Gamma P.1, Delta B.1.617.2 + AY.X, and Omicron B.1.1.529 VOCs are represented as magenta, yellow, cyan, forest green, and blue spheres, respectively. The shared mutated residues present in at least two VOCs are reported as red spheres.
Similar articles
-
SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021.
Alkhatib M, Svicher V, Salpini R, Ambrosio FA, Bellocchi MC, Carioti L, Piermatteo L, Scutari R, Costa G, Artese A, Alcaro S, Shafer R, Ceccherini-Silberstein F. Alkhatib M, et al. Microbiol Spectr. 2021 Dec 22;9(3):e0109621. doi: 10.1128/Spectrum.01096-21. Epub 2021 Nov 17. Microbiol Spectr. 2021. PMID: 34787497 Free PMC article.
-
Rochman ND, Faure G, Wolf YI, Freddolino L, Zhang F, Koonin EV. Rochman ND, et al. mBio. 2022 Apr 26;13(2):e0013522. doi: 10.1128/mbio.00135-22. Epub 2022 Mar 15. mBio. 2022. PMID: 35289643 Free PMC article.
-
Saxena SK, Kumar S, Ansari S, Paweska JT, Maurya VK, Tripathi AK, Abdel-Moneim AS. Saxena SK, et al. J Med Virol. 2022 Apr;94(4):1738-1744. doi: 10.1002/jmv.27524. Epub 2022 Jan 11. J Med Virol. 2022. PMID: 34905235
-
The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.
Akkız H. Akkız H. Front Med (Lausanne). 2022 May 20;9:849217. doi: 10.3389/fmed.2022.849217. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35669924 Free PMC article. Review.
-
Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
Jung C, Kmiec D, Koepke L, Zech F, Jacob T, Sparrer KMJ, Kirchhoff F. Jung C, et al. J Virol. 2022 Mar 23;96(6):e0207721. doi: 10.1128/jvi.02077-21. Epub 2022 Mar 23. J Virol. 2022. PMID: 35225672 Free PMC article. Review.
Cited by
-
In silico design of refined ferritin-SARS-CoV-2 glyco-RBD nanoparticle vaccine.
Masoomi Nomandan SZ, Azimzadeh Irani M, Hosseini SM. Masoomi Nomandan SZ, et al. Front Mol Biosci. 2022 Sep 6;9:976490. doi: 10.3389/fmolb.2022.976490. eCollection 2022. Front Mol Biosci. 2022. PMID: 36148012 Free PMC article.
-
Lan PD, Nissley DA, O'Brien EP, Nguyen TT, Li MS. Lan PD, et al. J Chem Phys. 2024 Feb 7;160(5):055101. doi: 10.1063/5.0188053. J Chem Phys. 2024. PMID: 38310477 Free PMC article.
-
SARS-CoV-2 Mutations and Variants May Muddle the Sensitivity of COVID-19 Diagnostic Assays.
Alkhatib M, Carioti L, D'Anna S, Ceccherini-Silberstein F, Svicher V, Salpini R. Alkhatib M, et al. Microorganisms. 2022 Aug 2;10(8):1559. doi: 10.3390/microorganisms10081559. Microorganisms. 2022. PMID: 36013977 Free PMC article.
-
Jiang M, Chen W, Chen Y, Chen J, Zhang Y, Yin H, Li Y, Liu W. Jiang M, et al. Diagn Microbiol Infect Dis. 2023 Feb;105(2):115860. doi: 10.1016/j.diagmicrobio.2022.115860. Epub 2022 Nov 12. Diagn Microbiol Infect Dis. 2023. PMID: 36459887 Free PMC article.
-
Neurological diagnoses in hospitalized COVID-19 patients during the B.1.1.529 surge.
Kim CY, Sardar Z, Ayele BA, Fleck-Derderian S, Barrett CE, Sun Y, Clague M, Hurst HA, Boruah A, Zucker J, Maddox R, Sejvar J, Thakur KT. Kim CY, et al. Ann Clin Transl Neurol. 2023 Aug;10(8):1433-1441. doi: 10.1002/acn3.51833. Epub 2023 Jun 23. Ann Clin Transl Neurol. 2023. PMID: 37350635 Free PMC article.
References
-
- World Health Organization. 2021. Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern. https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.....
-
- European Centre for Disease Prevention and Control. 2021. Threat assessment brief: implications of the emergence and spread of the SARS-CoV-2 B.1.1. 529 variant of concern (Omicron) for the EU/EEA. https://www.ecdc.europa.eu/en/publications-data/threat-assessment-brief-....
-
- Centers for Disease Control and Prevention. 2021. Science brief: Omicron (B.1.1.529) variant. https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/scienti.... - PubMed
-
- Venkatakrishnan A, Praveen A, Patrick L, Rohit S, Bharathwaj R, Michiel JN, Venky S. 2021. Omicron variant of SARS-CoV-2 harbors a unique insertion mutation of putative viral or human genomic origin. OSF Preprints. 10.31219/osf.io/f7txy. - DOI
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous